Lunai Bioworks Inc.
Lunai Bioworks Inc. (LNAI) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
lnai · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Lunai Bioworks Inc. (LNAI) measures how much investors pay for each dollar of the company's trailing earnings. LNAI's current PE ratio of N/A is calculated by dividing its stock price of $2.37 by its TTM earnings per share of -$41.06.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2021 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Lunai Bioworks Inc.You LNAI | $11M | N/A | — | -$41.06 |
 Adaptimmune Therapeutics plc ADAP | $75M | N/A | — | -$0.28 |
 Adlai Nortye Ltd. ANL | $543M | N/A | — | -$3.33 |
 Apollomics, Inc. APLM | $15M | N/A | — | -$7.57 |
 BioLineRx Ltd. BLRX | $14M | N/A | — | -$0.29 |
 Ernexa Therapeutics Inc. ERNA | $2M | N/A | — | -$55.83 |
 GeoVax Labs, Inc. GOVX | $1M | N/A | — | -$22.40 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | — | $-86.27 | — | |
2024-06-30 FY2024 | — | $-72.55 | — | |
2023-06-30 FY2023 | — | $-56.42 | — | |
2022-06-30 FY2022 | — | $-172.76 | — | |
2021-06-30 FY2021 | — | $-45.33 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Lunai Bioworks Inc. (LNAI) measures how much investors pay for each dollar of the company's trailing earnings. LNAI's current PE ratio of N/A is calculated by dividing its stock price of $2.37 by its TTM earnings per share of -$41.06.
Frequently asked questions
LNAI pe ratio · 6 questionsLNAI's current PE ratio is N/A as of 2026-06-08, based on a stock price of $2.37 and TTM EPS of -$41.06. Data sourced from Financial Modeling Prep via LNAI's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Lunai Bioworks Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08